Ayurvedic management of PCOS.

Management of Artava Dushti w.s.r to Polycystic Ovarian Syndrome with Virechana and Pathadi Kwatha â?? A randomized controlled clinical trial

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/02/007970

Enrollment

Registered

2017-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Artava Dushti Health Condition 2: E748- Other specified disorders of carbohydrate metabolism

Interventions

Intervention1: group A: virechana with trivrutavleha then pathadi kwatha 2o ml B.D. total duration 2 months. Intervention2: group B: only pathadi kwatha 20 ml b.d. total duration 2 months Control Int

Eligibility

Inclusion criteria

Inclusion criteria: Amenorrhoea or Oligomenorrhoea, Anovulatory infertility, Acne, Hirsutism, Obesity, Acanthosis nigricans.

Exclusion criteria

Exclusion criteria: Patients suffering from Pelvic/Systemic diseases like( Endometriosis, Hydrosalphinx, Fibroid uterus) causing Oligomenorrhoea and Anovulation.Organic lesions of reproductive tract like T.B, Carcinoma and Congenital deformities,uncontrolled Hypertension, uncontrolled Diabetes Mellitus, Hepatic/Renal disease, Cushingâ??s syndrome, Cardiac diseases, Age group 40 yrs

Design outcomes

Primary

Measure	Time frame
Subjective-:improvement in Clinical Features: Menstrual pattern (duration, interval), weight reduction, Hirsutism, Acanthosis nigricans, Acne. Timepoint: 60 days	—

Secondary

Measure	Time frame
Reduction in volume of ovary and size of cystTimepoint: 60 days	—

Countries

India

Contacts

Public ContactPROF Laxmi priya dei

IPGT and RA Jamnagar

deilaxmipriya@yahoo.com9228198366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026